- Country: Croatia
- Summary: Other Medications Ii; Groups - Group 1: Pancreatic Group, Group 2: Mesalazine 250 Mg, Group 3: Flakloxacylin, Group 4: Mesalazin Klizma, Group 5: Mesalazin Supp., Group 6: Sitagliptin, Gr ...
- HRT Ref No: 57603136
- Deadline: 18 Oct 2021
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: BAM 4448900.00
- Notice Type: Tender
- Document Ref. No.: 2021/S 0F2-0033542
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Other medications II; Group 1: Pancreatic Group (Highly), Group 2: Mesalazine 250 mg, Group 3: Flakloxacylin, Group 4: Mesalazin Klizma, Group 5: Mesalazin Supp., Group 6: Sitagliptin, Group 7: Sitagliptin + Metformin, Group 8 : Amitrombin III, Group 9: Rituksimab - Mabthera, Otop. for supcut.inj.bec. 1x400mg, group 10: noradrenalin (norepinefrin), group 11: levosimendan, group 12: mometasone, group 13: propiverin chloride, group 14: amphotericin B, group 15: imipenem + cilastin, group 16: ledipasvir + sofosbuvir, group 17: amantadine , Group 18: dimethyl fumarate 240 mg, Group 19: FluKloxacillin, Group 20: Jodoxanol 320, Group 21: Jobitridol 350, 200 ml, Group 22: Jobitridol 350, 100 ml, Group 23: Bortezomib, Group 24: Lauromacragol 400 (Poliodocanol ) Sol. 1%, Group 25: Lauromacrogol 400 (polyidocanol) 0.25%, Group 26: Lauromacrogol 400 (Poliodocanol) 0.5%, Group 27: Lauromomrogol 400 (by
Client: General Hospital Dr.ivo Pedišić-Sisak
Tag / number: 2021 / s 0F2-0033542
: 2021 / S 182-473061Plassing publishes in TED
Name: Other Medications II
Document type *: Tender Notice
Type of contract: Delivery of goods
CPV: 33600000-6 Pharmaceutical products
... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINOther Medications Ii; Groups - Group 1: Pancreatic Group, Group 2: Mesalazine 250 Mg, Group 3: Flakloxacylin, Group 4: Mesalazin Klizma, Group 5: Mesalazin Supp., Group 6: Sitagliptin, Gr ... - Croatia Tender
The GENERAL HOSPITAL DR. SAVI PEDIŠIĆ-SISAK, a Government sector organization in Croatia, has announced a new tender for Other Medications Ii; Groups - Group 1: Pancreatic Group, Group 2: Mesalazine 250 Mg, Group 3: Flakloxacylin, Group 4: Mesalazin Klizma, Group 5: Mesalazin Supp., Group 6: Sitagliptin, Gr .... This tender is published on CroatiaTenders under HRT Ref No: 57603136 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2021-10-18.
The estimated tender value is BAM 4448900.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
